Rick Lambert, MD | |
305 W Grand Ave, Montvale, NJ 07645-1813 | |
(201) 326-4788 | |
(201) 649-1798 |
Full Name | Rick Lambert |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 40 Years |
Location | 305 W Grand Ave, Montvale, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1891739421 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA05016100 (New Jersey) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kayal Medical Group, Llc | 2961894019 | 64 |
News Archive
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis by a University of Michigan team.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.
Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.
› Verified 7 days ago
Entity Name | In-balance Health, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790938819 PECOS PAC ID: 8325103146 Enrollment ID: O20090211000530 |
News Archive
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis by a University of Michigan team.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.
Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.
› Verified 7 days ago
Entity Name | Kayal Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528729159 PECOS PAC ID: 2961894019 Enrollment ID: O20220121001364 |
News Archive
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis by a University of Michigan team.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.
Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Rick Lambert, MD 305 W Grand Ave, Montvale, NJ 07645-1813 Ph: (201) 326-4788 | Rick Lambert, MD 305 W Grand Ave, Montvale, NJ 07645-1813 Ph: (201) 326-4788 |
News Archive
Suicides and drug overdoses kill American adults at twice the rate today as they did just 17 years ago, and opioids are a key contributor to that rise, according to a new review and analysis by a University of Michigan team.
Bristol-Myers Squibb Company today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that Daklinza (daclatasvir), an investigational, potent pan-genotypic NS5A complex inhibitor (in vitro), be granted approval for use in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Endocyte, Inc., a biotech company developing guided therapeutics and diagnostics for personalized medicine, has announced that an independent data safety monitoring board (DSMB) recommended that enrollment into the PRECEDENT study continue.
Annually about 2000 Danish patients with colorectal cancer are treated with chemotherapy. Today, a range of different chemotherapeutic regimens are available. However, deciding which regimen to use is not easy.
› Verified 7 days ago
Dr. Gabriela Wojnarska-alvarez, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 221 W Grand Ave, Suite 105, Montvale, NJ 07645 Phone: 101-746-9333 Fax: 201-746-9335 | |
Dr. Elizabeth Ann Kulesza, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7 Stem Brook Rd, Montvale, NJ 07645 Phone: 201-476-0196 | |
Dr. Sakina Firoz Dinani, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W Grand Ave Ste 900, Montvale, NJ 07645 Phone: 201-677-8680 Fax: 888-425-6116 | |
Dr. Rebecca M Varghese, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 E Grand Ave, Montvale, NJ 07645 Phone: 201-775-1153 Fax: 845-675-5005 | |
Ping Gu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Avenue, Montvale, NJ 07645 Phone: 201-775-7183 Fax: 201-691-6661 | |
Dr. Anupama Doraiswamy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7000 | |
Dr. Anuja Kriplani, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 225 Summit Ave, Montvale, NJ 07645 Phone: 201-775-7443 |